Immediate reactions following the first dose of the SARS-CoV2 mRNA vaccines do not preclude second dose administration

Link to article at PubMed

Clin Infect Dis. 2021 May 14:ciab448. doi: 10.1093/cid/ciab448. Online ahead of print.


Addressing COVID19 vaccine hesitancy and minimizing potential vaccine contraindications are critical to combat the ongoing pandemic. We describe a practical approach to immediate adverse events after the first dose of the SARS-CoV2 mRNA vaccines, focusing on allergic reactions with respect to their diagnosis and management.

PMID:33989390 | DOI:10.1093/cid/ciab448

Leave a Reply

Your email address will not be published.